Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Zidovudine after occupational exposure to HIV.

Literature DB >> 2059707

Zidovudine after occupational exposure to HIV.

D J Jeffries.

Abstract

Entities: Chemical

Mesh：

Substances：
Zidovudine

Year: 1991 PMID： 2059707 PMCID： PMC1670072 DOI： 10.1136/bmj.302.6789.1349

Source DB: PubMed Journal: BMJ ISSN： 0959-8138

× No keyword cloud information.

10 in total

1. Failed prophylactic zidovudine after needlestick injury.

Authors: D F Looke; D I Grove
Journal: Lancet Date: 1990-05-26 Impact factor: 79.321

2. Failure of zidovudine prophylaxis after accidental exposure to HIV-1.

Authors: J M Lange; C A Boucher; C E Hollak; E H Wiltink; P Reiss; E A van Royen; M Roos; S A Danner; J Goudsmit
Journal: N Engl J Med Date: 1990-05-10 Impact factor: 91.245

3. Functional evidence for an RNA template in telomerase.

Authors: D Shippen-Lentz; E H Blackburn
Journal: Science Date: 1990-02-02 Impact factor: 47.728

4. 3'-Azido-3'-deoxythymidine in feline leukemia virus-infected cats: a model for therapy and prophylaxis of AIDS.

Authors: L Tavares; C Roneker; K Johnston; S N Lehrman; F de Noronha
Journal: Cancer Res Date: 1987-06-15 Impact factor: 12.701

5. Soluble CD4 enhances simian immunodeficiency virus SIVagm infection.

Authors: A Werner; G Winskowsky; R Kurth
Journal: J Virol Date: 1990-12 Impact factor: 5.103

6. Surveillance of health care workers exposed to blood from patients infected with the human immunodeficiency virus.

Authors: R Marcus
Journal: N Engl J Med Date: 1988-10-27 Impact factor: 91.245

7. Suppression of mouse viraemia and retroviral disease by 3'-azido-3'-deoxythymidine.

Authors: R M Ruprecht; L G O'Brien; L D Rossoni; S Nusinoff-Lehrman
Journal: Nature Date: 1986 Oct 2-8 Impact factor: 49.962

8. Prophylactic zidovudine after occupational exposure to the human immunodeficiency virus: an interim analysis.

Authors: D K Henderson; J L Gerberding
Journal: J Infect Dis Date: 1989-08 Impact factor: 5.226

9. Enhancement of SIV infection with soluble receptor molecules.

Authors: J S Allan; J Strauss; D W Buck
Journal: Science Date: 1990-03-02 Impact factor: 47.728

10. Infection of the SCID-hu mouse by HIV-1.

Authors: R Namikawa; H Kaneshima; M Lieberman; I L Weissman; J M McCune
Journal: Science Date: 1988-12-23 Impact factor: 47.728

10 in total

16 in total

Zidovudine after occupational exposure to HIV.

1. Failed prophylactic zidovudine after needlestick injury.

2. Failure of zidovudine prophylaxis after accidental exposure to HIV-1.

3. Functional evidence for an RNA template in telomerase.

4. 3'-Azido-3'-deoxythymidine in feline leukemia virus-infected cats: a model for therapy and prophylaxis of AIDS.

5. Soluble CD4 enhances simian immunodeficiency virus SIVagm infection.

6. Surveillance of health care workers exposed to blood from patients infected with the human immunodeficiency virus.

7. Suppression of mouse viraemia and retroviral disease by 3'-azido-3'-deoxythymidine.

8. Prophylactic zidovudine after occupational exposure to the human immunodeficiency virus: an interim analysis.

9. Enhancement of SIV infection with soluble receptor molecules.

10. Infection of the SCID-hu mouse by HIV-1.

1. Purchasing care for people with HIV infection and AIDS.

2. Trainees' knowledge of AIDS and HIV.

3. Doctors, patients, and HIV.

4. Zidovudine after occupational exposure to HIV.

5. Zidovudine after occupational exposure to HIV.

6. Zidovudine after exposure to HIV.

7. Zidovudine after occupational exposure to HIV.

8. Zidovudine after occupational exposure to HIV.

9. Zidovudine after occupational exposure to HIV.

Review 10. Clinical pharmacology of zidovudine and other 2',3'-dideoxynucleoside analogues.